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background
The aim of the case study was to describe the profile of 
cognitive and emotional functioning of a patient with pos-
sible progressive supranuclear palsy (PSP) from a longitu-
dinal perspective.
participants and procedure
This study involved an 71-year-old male patient diagnosed 
with PSP, and 9 matched healthy subjects. Neuropsycho-
logical examination of the patient was performed twice with 
a 6-month interval. A set of neuropsychological tests was 
used to assess both cognition and behaviour.
results
Neuropsychological assessment revealed executive dys-
function dominance (planning deficits, reduced cognitive 
flexibility and abstract thinking, impulsiveness), reduced 
verbal fluency, psychomotor slowness and problems with 
memory retrieval from the long-term memory storage in 
contrast to significantly better recognition of the previ-
ously learned information. According to emotional func-
tioning, frontal change of personality was observed, with 
apathy, disinhibition, lack of insights, impulsiveness and 
“utilization behaviours”. 
conclusions
The profile of emotional and cognitive impairments met the 
criteria for dementia. There was a progression of deficits at 
visit two in comparison to visit one. The longitudinal per-
spective allowed the dynamics of emotional, cognitive and 
behavioural changes to be described over time: from de-
pression related to initially preserved criticism of the illness 
to apathy and emotional blunting and behavioural frontal 
syndrome connected with the systematic loss of insight.
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Background
Progressive supranuclear palsy (PSP), also named 
Steele–Richardson–Olszewski disease, is a  neuro- 
degenerative illness, classified as one of the Parkin-
son-plus syndromes. The atrophy affects mainly the 
brainstem, diencephalon, frontal lobes, sometimes 
the precentral gyrus and the postcentral gyrus, 
superior cerebellar peduncles and the dentate nu-
cleus (Steele, Richardson, & Olszewski, 1964; Jelic, 
Nennesmo, Palhagen, &  Winblad, 2011; Sitburana 
& Ondo, 2009; Hauw & Agid, 2003). The exact etiol-
ogy of the disease is not known yet but the evidence 
suggests that it is due to abnormal deposition of tau 
protein in neuronal tissues (Motyl, 2007). Its preva-
lence is approximately 5 cases per 100 000 (Nath et 
al., 2001; Bower, Maraganore, McDonnell, & Rocca, 
1997). It starts mostly in the middle or older age 
(Williams & Lees, 2009) and the median survival is 
6-12 years (Williams & Lees, 2010). The neurologi-
cal symptoms of PSP include stiffness, bradykine-
sia, postural instability with frequent falls, supra-
nuclear gaze palsy in the vertical direction, apraxia 
of eyelid opening and closing, dysarthria and dys-
phagia. Cognitive and emotional impairments, 
as well as personality changes, are also noticed 
(Houghton & Litvan, 2007; Burn & Lees, 2002). In 
the neuropsychiatric profile of PSP patients apathy 
is found to be the most common negative symptom 
(Gerstenecker, Duff, Mast, & Litvan, 2013; Rittman, 
Coyle-Gilchrist, &  Rowe, 2016). PSP is often un-
derdiagnosed and must be distinguish from other 
movement disorders such as Parkinson’s disease 
(PD), multiple system atrophy (MSA), corticobasal 
degeneration (CBD) and dementia with Lewy bod-
ies (DLB) (Armstrong, 2011). Describing the neu-
ropsychological profile of cognitive impairments 
of PSP patients could be helpful in the diagnosis. 
In our case report we describe the cognitive, be-
havioural and emotional course of a  PSP patient. 
We performed the neuropsychological examination 
twice, with a 6-months interval between examina-
tions, which gave an opportunity to observe the 
progress of neuropsychological deficits. To the best 
of our knowledge there is a lack of PSP case reports 
showing the cognitive impairments from the longi-
tudinal perspective. 
ParticiPants and Procedure
A 71-year-old patient with 10 years of formal educa-
tion, a retired professional turner, was re-admitted 
to the Department of Neurology with a diagnosis of 
unspecified parkinsonism and suspected progres-
sive supranuclear palsy. The patient reported symp-
toms of psychomotor slowness, difficulty in walking, 
the presence of falling backwards, lower volume of 
speech and swallowing problems. In terms of cog-
nitive processes, slowness of thought and difficulty 
of making decisions were observed. The patient 
denied memory problems. He reported depressed 
mood, suicidal tendencies and uncontrolled crying 
which appeared few years ago. In recent MRI of the 
head leukoaraiosis around the lateral ventricles was 
observed. In the corona radiata and centrum semi-
ovale white matter, numerous, predominantly small 
(5 mm), subcortical frontoparietal zones of vascular 
changes were revealed (Figure 1). The ventricular 
system was slightly enlarged, reflecting the subcor-
tical brain atrophy (Figure 2). Moderate cortical at-
rophy of the brain was also revealed. MRI revealed 
thinning of the head midbrain in the cross-sectional 
view (Figure 3).
With regards to the control group, 10 potential 
participants were recruited from Krakow Rehabili-
tation Center (treated for spinal degeneration) and 
carefully screened in order to identify persons with 
no significant health problems such as cognitive im-
pairment, hypertension or neuropsychiatric disor-
ders. At the end of the screening stage, 9 healthy con-
trols (six males, mean age 69.30 ±6.52 years, range 
66-74 years, mean years of formal education 10.00 
±1.33) took part in the study. In order to exclude 
from the control group subjects with possible cog-
nitive impairment, we only included patients with 
a  Mini Mental State Examination (MMSE) score 
> 26  (M = 28.50, SD = 0.07, range 27-29) and with 
no history of medical or psychological conditions 
known to be associated with cognitive problems.
Figure 1. Atrophy of the area of the midbrain – cross 
section (MRT2 midbrain).
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Medical exaMination
Electroencephalographic examination showed a  re-
cord with slight retardation and reduced reactivity of 
the basic rhythm. The alpha wave range was 8-9 Hz 
with amplitude of 40 μV in parietal-occipital leads.
Intracranial ultrasound examination showed that 
all visible vessels were unobstructed with the normal 
blood velocity. 
Ultrasound revealed bilateral patent carotid arter-
ies, IM thickened up to 1.20 mm. Vertebral and ca-
rotid arteries were patent bilaterally with symmetric 
blood flow towards the brain.
Neurological examination showed the presence of 
hypomimia, lack of vertical eye movement, reduced 
spontaneous speech with monotonous prosody and 
dysarthria. The reflexes of the base were disturbed. 
Muscle tension was increased with symmetrical bra-
dykinesia. There was a resting and position tremor in 
the upper limbs. The walk was sliding with limited 
balancing of the upper limbs. Steps were small with 
“freezing”. The patient made the whole body turn, 
but in an unstable way. 
The neurologopedic examination showed pho-
natory disorders and aphonia. The patient’s speech 
was voiced with correct articulation and understand-
able. Aprosodia of speech was present because of the 
whispered speech. 
The patient did not respond to levodopa (500 mg dai-
ly). He did not have any significant general health co-
morbidities (e.g. hypertension) at the time of this study.
neuropsychological exaMination
The neuropsychological examination was performed 
twice at a 6-month interval and included observation 
of the behaviour and an interview with the patient and 
his wife supplemented with the Dysexecutive Ques-
tionnaire (DEX) from the BADS battery (Behavioural 
Assessment of the Dysexecutive Syndrome) and the 
Frontal Behaviour Inventory Questionnaire (Kertesz, 
Davidson, & Fox, 1997; Pąchalska & MacQueen, 1998), 
the Mini Mental State Examination (MMSE; Folstein, 
Folstein, & McHuhg, 1975), the Auditory Verbal Learn-
ing Test by Luria (AVLT; Łuria, 1976; Taralowska, 
Florkowski, Orzechowska, Zboralski, & Gałecki, 2011), 
Luria’s Memory Words Test (LMWT; Luria, 1962; Ar-
dila, 1992), the Weigl Color Form Sorting Test (CFST), 
the Wisconsin Card Sorting Test (WCST), the Trial 
Making Test (TMT), the Verbal Fluency Test (VFT) 
(Piskunowicz, Bieliński, Zgliński, & Borkowska, 2013), 
the Frontal Assessment Battery at bedside (FAB), the 
Clock Drawing Test, a  copy of a  cube, the experi-
mental task of crossing out letters E and R, and the 
Frenchay Aphasia Screening Test (FAST) (Enderby, 
Wood, Wade, & Hewer, 1986). The control group was 
examined once with the same methods.
Descriptive statistical analyses were performed 
with Statistical Package for the Social Sciences 
21  (SPSS 21). Comparisons of the patient’s scores 
with healthy controls’ scores were performed by 
means of a modified t-test, according to the proce-
dure described by Crawford, Howell and Garthwaite 
(1998) and Crawford and Garthwaite (2002) to deal 
with single cases in cognitive neuropsychology.
In the first place, the patient’s scores on the neu-
ropsychological measures from the first examination 
(T1) were compared to the scores of the healthy con-
trol group. Subsequently, in order to show longitu-
dinal changes and to monitor the patient’s cognitive 
functioning over time, his scores from the examina-
tion which took place six months later (T2) were 
compared with the scores of healthy controls.
Figure 2. Subcortical brain atrophy (MRI coronal T2 
subcortical atrophy).
Figure 3. Sagittal projection (MRI sagittal T2 projec-
tion).
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results
The patient and 9 healthy controls recruited for this 
study were comparable in terms of both age and level 
of formal education. Table 1 presents demographic 
data of the PSP patient and the healthy controls.
The patient’s and the healthy controls’ scores and 
the statistical comparisons are shown in Table 2.
The comparisons between the patient and the 
control group show that: In the first (T1) and second 
examination (T2) the patient’s scores were signifi-
cantly worse than the healthy control group’s scores 
on the MMSE measure (T1: t(9)  =  15.65, p  =  .001; 
T2: t(9) = 29.07, p < .001). The patient obtained signifi-
cantly worse scores on the LMWT, both in the first 
examination [T1: third repetition t(9) = 3.75, p = .005, 
fourth repetition t(9) = 5.02, p = .001, fifth repetition 
t(9) = 10.09, p < .001, distraction: t(9) = 6.91, p < .001 and 
recognition: t(9) = 4.12, p = .003)] and in the second 
examination [T2: first repetition t(9) = 4.71, p = .001, 
second repetition t(9) =  3.28, p  =  .010, third repeti-
tion t(9) = 6.09, p < .001, fourth repetition t(9) = 5.02, 
p < .001, fifth repetition t(9) = 7.36, p < .001, distrac-
tion: t(9) = 6.91, p < .001 and recognition: t(9) = 7.06, 
p <  .001)]. The patient’s time of performance in the 
TMT test was significantly longer than that of the 
control group [T1: part A time t(9) = –12.08, p < .001; 
part B time t(9) = –12.55, p <  .001; T2: part A time 
t(9)  =  –36.46, p  <  .001; part B time t(9)  =  –35.89, 
p <  .001]. The patient made significantly more mis-
takes in the TMT test in both examinations [T1: part 
Table 2 
PSP Patient and control group comparison on general neuropsychological measures separately for the first and 
the second examination
Dependent variable PSP 
patient  
T1
Healthy 
controls 
(SD) 
(n = 9)
t(9) 
T1
p 
T1
PSP 
patient  
T2
t(9) 
T2
p 
T2
LMWT / 1 4 4.60 (1.07) 1.77 .111 3 4.71 .001
LMWT / 2 6 6.40 (1.35) 0.94 .373 5 3.28 .010
LMWT / 3 6 7.60 (1.35) 3.75 .005 5 6.09 < .001
LMWT / 4 6 7.90 (1.2) 5.02 .001 6 5.02 .001
LMWT / 5 5 8.70 (1.16) 10.09 < .001 6 7.36 < .001
LMWT / distraction 4 7.60 (1.65) 6.91 < .001 4 6.91 < .001
LMWT / recognition 8 9.40 (1.07) 4.12 .003 7 7.06 < .001
TMT part A / time 175 70.90 (27.25) –12.08 < .001 385 -36.46 < .001
TMT part A / mistakes 1 0.10 (0.32) –9.00 < .001 0 1.00 .343
TMT part B / time 330 151.50 (44.98) –12.55 < .001 662 –35.89 < .001
TMT part B / mistakes 16 0.70 (0.67) –71.68 < .001 5 –20.15 < .001
VFT / semantic 10 16.20 (4.24) 4.63 .001 9 5.37 < .001
VFT / letter 6 11.30 (3.47) 4.84 .001 7 3.92 .003
VFT / letter / mistakes 2 0.20 (0.42) –13.50 < .001 0 1.50 .168
MMSE 25 28.50 (0.71) 15.65 < .001 22 29.07 < .001
CDT 10 9.90 (0.32) –1.00 .343 10 –1.00 .343
Note. T1 – first neuropsychological assessment: at the beginning of the study; T2 – second neuropsychological assessment: after 
six months; LMWT – Luria Memory Words Test; TMT – Trial Making Test; VFT – Verbal Fluency Test; MMSE – Mini Mental State 
Examination Test; CDT – Clock Drawing Test.
Table 1
Demographic data
PSP 
patient
Healthy 
controls 
(SD) 
(n = 9)
t(9) p
Age in years 71 69.30 (6.52) –.83 .431
Gender (M : F) 1 : 0 6 : 3
Education in 
years 
10 10 (1.33) .00 1.00
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A number of mistakes t(9) = –9.00, p <  .001; part B 
number of mistakes t(9) = –71.68, p < .001; T2: part A 
number of mistakes NS; part B number of mistakes 
t(9)  =  –20.15, p  <  .001]. The patient scored signifi-
cantly worse on semantic fluency VFT-semantic [T1: 
t(9) = 4.63, p = .001; T2: t(9) = 5.37, p < .001]; and pho-
nological fluency VFT-letters [T1: t(9) = 4.84, p = .000; 
T2: t(9) = 3.92, p = .003]. In other neuropsychological 
measures administered (CDT, FAST, CFST), the pa-
tient’s performance did not differ significantly from 
healthy controls’ performance.
In the measures without possibility of compari-
son to the norms (FBI, FAB, DEX, WCST, a copy of 
a cube, task of crossing out letters E and R), a descrip-
tive analysis is presented below. We also present the 
qualitative analysis of performance in the neuropsy-
chological examination. 
In the executive measures: in the WCST test the 
patient was able to finish only one category with-
out the ability of mental switching for another one 
(the score was impossible to compare with norms). 
Numerous perseveration errors occurred. Finally, the 
patient gave up the task due to significant fatigue. 
Execution of the Frontal Assessment Battery (FAB) 
at bedside presented a significant problem with the 
go/no go task, susceptibility to interference, and re-
action inhibition problems. The Dysexecutive Ques-
tionnaire (DEX) and Frontal Behaviour Inventory 
Questionnaire (FBI) revealed a  decline in criticism, 
lack of shame and social embarrassment, decreased 
flexibility in thinking, impulsiveness, “utilization 
behaviours”, problems with abstract thinking, plan-
ning and organizing everyday activities and logope-
nia. The memory functions were relatively well pre-
served, especially long-term memory.
Language functions and verbal fluency: the Ver-
bal Fluency Test revealed impaired semantic fluency 
and letter fluency; vulgar words and perseverations 
appeared. The language functions were preserved, 
without typical aphasic speech impairments such 
as problems with understanding or naming (the 
Frenchay Aphasia Screening Test results), but aprax-
ia of speech was present.
Visuospatial and constructive processes: During 
the cube copy constructive apraxia was observed. 
Further praxis examination revealed dynamic dys-
praxia (the patient had difficulty with motor plan-
ning), and preserved spatial and symbolic (ideo-
motor) praxis. In the second neuropsychological 
examination dyspraxia was more visible.
Mental speed: The slowness of performance in the 
experimental task of crossing out the letters E and R 
(first examination: 3 minutes and 36 seconds, second 
examination: 3 minutes and 35 seconds) proved psy-
chomotor retardation.
In the behaviour observation psychomotor slow-
ness, difficulty with starting the activities and resting 
tremors were observed. Bradykinesia and problems 
with balance were present during walking. Eyes re-
mained fixed in a constant staring upward gaze, de-
picting supranuclear horizontal and vertical gaze pal-
sies. The facial expression was poor (face dystonia). 
The speech was dysarthric and aphonic. 
In the interview with the subject’s wife the follow-
ing dysexecutive problems were reported: a decline 
in criticism, lack of shame and social embarrassment, 
decreased flexibility in thinking, impulsiveness and 
“utilization behaviours” – strong need for touching 
objects that were within his reach. There were also 
problems with abstract thinking, planning and orga-
nizing everyday activities. The patient became signif-
icantly less talkative (logopenia). Memory functions 
were relatively well preserved, especially long-term 
memory. In terms of emotional functioning, the wife 
reported occurrence of sadness, anxiety and depres-
sion, withdrawal from social contact, emotional in-
difference in some situations and a lack of empathy. 
Depression was found at the beginning of the illness, 
while in time more symptoms of apathy appeared.
discussion
The described patient presented gait instability, fre-
quent falls, abnormal eye movements and the early 
onset of subcortical dementia with the frontal-exec-
utive syndrome, which strongly suggest PSP as the 
most likely diagnosis. According to the cognitive 
and emotional characteristics, executive dysfunction 
dominance was observed. It manifested with planning 
deficits, reduced cognitive flexibility and abstract 
thinking, and increased impulsiveness. Problems in 
metacontrol of intentional behaviour were present. 
Frontal lobe paradox was observed with dissocia-
tion between knowledge and action. Susceptibility to 
interference and reaction inhibition problems were 
also significant. The executive decline in PSP has also 
been confirmed in other research which showed its 
impact on quality of life (Pekmezović et al., 2015) and 
activities of daily living (Litvan & Kong, 2014). More-
over, reduced verbal fluency, psychomotor slowness 
and problems with memory retrieval were also pres-
ent. The deficit of letter fluency was similar to the 
results of Rittman et al. (2013, 2016) and helped us 
to state that our patient was more likely to have the 
syndrome of PSP rather than idiopathic PD. The ob-
served level of cognitive functioning can be charac-
terized as frontal-subcortical dementia, described in 
the literature as one of the most pathognomonic signs 
of PSP. The research in this field indicates that cogni-
tive impairment develops in almost all patients with 
PSP, and the characteristic features for subcortical 
dementia include slowness of information process-
ing and thinking, difficulty in working memory, and 
attention deficits (especially task switching) (Liber-
ski, Sobów, & Wszołek, 2005). However, the descrip-
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tion of PSP as a subcortical dementia is incomplete 
(Ferrara & Litvan, 2011) as frontal lobe pathology is 
also present (Paviour, Price, Jahanshahi, Lees, & Fox, 
2006). Patients with PSP exhibit executive dysfunc-
tions manifested by cognitive inflexibility and dif-
ficulties with problem solving. Difficulties are also 
evident in tasks that require abstract thinking (Walsh 
& Darby, 2008; Ferrara & Litvan, 2011).
The memory impairments with a frontal like pro-
file (manifested with bad retrieval but relatively good 
memory storage and disorganized auditory learning 
process – with no mnemonic strategy) were relative-
ly small compared to the dysexecutive syndrome. The 
results of the two memory examinations were com-
parable after 6 months, without significant progres-
sion in memory impairment. This result is consistent 
with other research, which shows that the function-
ing of memory in PSP is better than in Parkinson’s 
disease with dementia, dementia with Lewy bodies 
and Alzheimer’s disease (Litvan, 1994; Dubois, Dee-
wer, &  Pillon, 1996; Aarsland et al., 2003). Patients 
usually perform relatively well on short-term mem-
ory tests. Verbal learning tasks show a  greater de-
terioration of recall, with much less disturbed word 
recognition (Ferrara & Litvan, 2011). 
Our patient manifested speech rather than lan-
guage problems, which can be defined as apraxia of 
speech with motor programming problems, articula-
tory impairments, prosody deficits, rhythm and into-
nation errors. The patient did not suffer from a lan-
guage deficiency (such as aphasia), but had difficulty 
in the production of language in an audible manner. 
This difficulty was mainly limited to vocal speech, and 
did not affect sign-language production. Moreover, 
the patient knew exactly what he wanted to say, but 
there was a disruption in the part of the brain that 
sent the signal to the muscle for the specific move-
ment. This symptom has been described in some PSP 
cases before, especially those with a  long follow-up 
(Kertesz, McMonagle, Blair, Davidson, &  Munoz, 
2005). However, some researchers claim that speech 
deficits in PSP are usually mild and disturbed verbal 
fluency is the most consistent impairment (Albert, 
Feldman, & Willis, 1974; Lange et al., 2003).
The psychiatric symptoms were the early signs of 
the illness in our patient. Their specificity in our pa-
tient supports frontal deficits with depression, emo-
tional lability and in the later course apathy, criticism 
decline, lack of empathy, emotional blunting and “uti-
lization behaviours”. Psychopathological symptoms 
characteristic for the frontal lobe syndrome could be 
observed relatively early in this disease course. Dis-
inhibition is a behavioural symptom observed in PSP 
that affects 30% to 50% of patients (Millar, Griffiths, 
& Zermansky, 2006). “Utilization behaviour” is also 
described, considered to be an extreme form of “en-
vironment-dependence syndrome” (Lhermitte, 1983). 
People with PSP often have preserved insight and are 
aware of their cognitive problems (Liberski, Sikorska, 
& Sobów, 2006), which may cause depression, apathy, 
aboulia and irritability. Apathy is a  major problem 
in PSP, which is independent from depression and 
affects approximately 90% of patients (Ferrara & Lit-
van, 2011). Hypochondriacal attitude and psychotic 
symptoms might also be present, but they are less 
common (Lauterbach, 2004; Millar et al., 2006). The 
occurrence of withdrawal from social contact, emo-
tional indifference and the lack of empathy in our 
patient can be explained in terms of brain atrophy 
in the frontal lobe (among other brain regions), such 
deterioration being linked with a  lack of empathy 
and emotional blunting (Steele et al., 1964; Jelic et 
al., 2011; Hillis, 2014). The diagnosis of PSP is never 
easy, and there are a few neurodegenerative diseases 
which should be considered and eliminated (Kertesz, 
Jesso, Harciarek, Blair, & McMonagle, 2010). For ex-
ample, progressive supranuclear palsy (PSP) and cor-
ticobasal degeneration (CBD) often clinically over-
lap. While PSP patients often have severe postural 
instability at onset, symmetric parkinsonism, vertical 
present lateralized motor (e.g., parkinsonism, dysto-
nia or myoclonus) and cognitive signs (e.g., ideomo-
tor apraxia, aphasia or alien limb) (Litvan et al., 1999), 
they were absent in the case of our patient. PSP may 
resemble DLB, but the occurrence of visual halluci-
nations, cognitive decline and fluctuating cognition 
with pronounced variation in attention and alertness 
may be helpful exclusion criteria of PSP (Liscic, Sru-
lijes, Gröger, Maetzler, & Berg, 2013). According to 
our patient, positive psychiatric symptoms, such as 
hallucinations, were absent. It is evident that PSP is 
not a purely movement disorder. As a  clinical syn-
drome it encompasses motor, cognitive, behavioural 
and language deficits that may overlap clinically 
with frontotemporal dementia (FTD), progressive 
nonfluent aphasia (PNFA) and to a small extent with 
semantic dementia (SD). What is more, although 
FTD and PNFA begin as cortical syndromes, they can 
evolve into CBD-like or PSP-like movement disorder. 
Significant differences still remain, however, between 
CBD, PSP and FTD. First, these three disorders have 
distinct anatomical patterns of degeneration: PSP is 
associated with extensive pathological changes in 
the cerebellum and pons, whereas CBD, PNFA and 
FTD generally spare this region. In FTD the most 
prominent atrophy is generally frontal, temporal or 
both. FTD is differentiable from CBD and PSP when 
behavioural impairments are dominant and the pa-
tient shows relatively spared language and memory 
function (Sha, Hou, Viskontas, &  Miller, 2007). Ac-
cording to our patient, the general pattern of deficits 
was reverse, with dominant cognitive problems and 
coexisting emotional impairments. However, recent 
research has shown the existence of a  spectrum of 
cognitive and behavioural features in PSP which 
overlap with behavioural variant FTD, e.g. disinhibi-
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tion, apathy, and executive impairments, and these 
disturbance may evolve over time (Kobylecki et al., 
2015). The overlap of PSP and PNFA has recently 
been reported, too. It has been proposed that PNFA, 
and in particular the presence of progressive apraxia 
of speech (AOS), predicts tau histopathologies, in-
cluding PSP. Rohrer (Rohrer et al., 2010) writes that 
some patients with PNFA may subsequently devel-
op characteristic features of PSP including a typical 
oculomotor palsy. The neuropsychological profile in 
these cases was similar to other patients with PNFA, 
but with more marked reduction in propositional 
speech, fewer speech errors, but more severely asso-
ciated deficits of episodic memory and praxis (Rohrer 
et al., 2010). This pattern of clinical and cognitive 
deficits in PSP-PNFA is consistent with the greater 
involvement of prefrontal areas and less marked in-
volvement of perisylvian areas. The patient with pro-
gressive speech apraxia and early marked impover-
ishment of propositional speech without prominent 
speech errors (present in our patient) should be ob-
served for development of the PSP syndrome (Rohrer 
et al., 2010). 
To sum up, according to the literature the de-
scribed patient did not present any other symptoms 
characteristic for these neurodegenerative diseases. 
To our knowledge, no effective treatment is avail-
able for PSP. A few studies have pointed towards the 
use of rivastigmine for PSP cognitive impairments 
(Nijboer & Dautzenberg, 2009). Taking into account 
the limitations of managing cognitive and behav-
ioural symptoms in PSP, non-pharmacological inter-
ventions are suggested as the first line of treatment, 
including education and support for caregivers (Rit-
tman et al., 2016). The role of a multispecialty treat-
ment team as well as family support is crucial in the 
management of this complex disease. We proposed 
neuropsychological rehabilitation to this patient. 
There were tasks for attention, executive functions 
and memory exercises which the patient performed 
every day together with his wife. He also had regu-
lar exercises with a  speech therapist. Interventions 
also included communication skills, education for the 
patient and his caregivers, exercises, and caregiver 
coping skills and guidance. In Poland it is still a rare 
and unpopular form of help for PSP patients, but we 
believe that it not only helps slow down the pro-
gression of cognitive decline but also gives a  sense 
of control over the illness situation, which in con-
sequence may reduce the depressive symptoms. Al-
though the interventions did not crucially improve 
scores on cognitive tests, thanks to neurorehabilita-
tion and a better understanding of the symptoms of 
the disease, the quality of life of the patient and care-
givers has improved.
What is notable in this case is the presence of PSP 
symptoms for 12 years while the average illness du-
ration is 5-12 years (Liberski et al., 2006; Williams 
& Lees, 2009). We suppose that, among other factors, 
the intense rehabilitation and family support may 
explain such a  long period of survival. The patient 
is still alive, so PSP may be confirmed at autopsy in 
the future. 
Strengths of the present study are the longitudi-
nal approach and the implementation of a modified 
t-test, specifically designed to deal with single case 
studies.
conclusions
The longitudinal perspective of the patient’s neuro-
psychological examination allowed us to describe the 
dynamics of behavioural changes over time. 
The neuropsychological progression of the illness 
included emotional and behavioural changes: from 
depression (related to initially preserved criticism of 
the illness), to emotional blunting, apathy and behav-
ioural frontal syndrome (connected with the system-
atic loss of insight). 
The profile of cognitive changes confirmed pro-
gressive subcortical-frontal neurodegeneration with 
increasing slowness and dysexecutive syndrome in 
contrast to memory, as well as visuospatial functions 
relatively well preserved. 
The executive impairment caused the patient’s 
growing dependence on the relatives and the inabili-
ty to use the preserved cognitive abilities in everyday 
life. In consequence the patient needs total care and 
help from his family.
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